OpenAI will soon shut down its Sora AI video-generation app, the company said in a surprising announcement Tuesday. Subscribe to read this story ad-free Get unlimited access to ad-free articles and ...

In January, OpenAI’s handpicked council of advisers on well-being and AI met with the company’s representatives for an update about a controversial new feature called “adult mode.” Citing the need to ...

ChatGPT's new interactive visuals are designed to make it easier for users to understand math and scientific concepts. (OpenAI) OpenAI is rolling out new interactive responses in ChatGPT it says are ...

About five months after U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. touted leucovorin as “an exciting therapy that may benefit large numbers of children who suffer ...

Compared with rituximab plus CHOP, CHOP-radioimmunotherapy demonstrated superior 15-year PFS (47 vs 34%). HealthDay News — For patients with untreated, advanced-stage follicular lymphoma (FL), ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

I recently saw a tweet showing how Google has acquired companies over the years and built products around them. Here is the link to the tweet if you want. Now, Google made another announcement: Google ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...

Pranay Parab is an independent tech journalist based in Mumbai, India. He covers tech for Lifehacker, and specializes in tutorials and in-depth features. Apple Music is testing a new AI playlist ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...